MULTIPLE-MYELOMA - COMPLETE REMISSION WITH HIGH-DOSE MELPHALAN CHEMOTHERAPY

被引：0
|
作者：
RICHARDS, F
COLEMAN, M
COOPER, MR
BALLARD, WP
机构：
[1] CORNELL UNIV, MED CTR,NEW YORK HOSP,COLL MED,DEPT MED, DIV HEMATOL ONCOL,ONCOL SECT,525 E 68TH ST, NEW YORK, NY 10021 USA
[2] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, ONCOL RES CTR, WINSTON SALEM, NC 27103 USA
来源：
CANCER INVESTIGATION | 1985年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [41] Pharmacodynamics of High-Dose Melphalan in Myeloma
    Nath, C. E.
    Joshua, D.
    Kerridge, I.
    Kwan, Y. L.
    Shaw, P. J.
    Trotman, J.
    Zeng, L.
    Presgrave, P.
    Tiley, C.
    McLachlan, A.
    Gurney, H.
    Earl, J.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S34 - S35
  • [42] DOSE INTENSITY ANALYSIS OF MELPHALAN AND PREDNISONE IN MULTIPLE-MYELOMA
    PALMER, M
    BELCH, A
    HANSON, J
    BROX, L
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (06) : 414 - 418
  • [43] INTERMEDIATE DOSE OF INTRAVENOUS MELPHALAN IN ADVANCED MULTIPLE-MYELOMA
    TSAKANIKAS, S
    PAPANASTASIOU, K
    STAMATELOU, M
    MANIATIS, A
    [J]. ONCOLOGY, 1991, 48 (05) : 369 - 371
  • [44] WHO BENEFITS FROM HIGH-DOSE THERAPY FOR MULTIPLE-MYELOMA
    ANDERSON, KC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (06) : 1291 - 1296
  • [45] ENHANCEMENT OF AMYLOIDOSIS BY HIGH-DOSE PREDNISOLONE THERAPY IN MULTIPLE-MYELOMA
    KANOH, T
    NAKAMURA, Y
    KAWAI, C
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (01) : 83 - 83
  • [46] SEQUENTIAL HIGH-DOSE CORTICOSTEROID-THERAPY IN MULTIPLE-MYELOMA
    ARLET, P
    LAROCHE, M
    ADOUE, D
    SALLERIN, F
    VILAIN, C
    JUCHET, H
    LETALLEC, Y
    [J]. PRESSE MEDICALE, 1988, 17 (09): : 439 - 439
  • [47] HIGH-DOSE CYCLOPHOSPHAMIDE - AN EFFECTIVE TREATMENT FOR REFRACTORY MULTIPLE-MYELOMA
    LENHARD, RE
    OKEN, MM
    HUMPHREY, RL
    BARNES, JM
    GLICK, JH
    BENNETT, JM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 537 - 537
  • [48] Achievement of Complete Remission After High-Dose Melphalan and Autologous Stem Cell Transplantation Is the Only Important Prognostic Factor in Patients with Multiple Myeloma
    Shin, Seunghwan
    Kim, Jeong-A
    Lee, Bohee
    Min, Chang Ki
    Kwak, Jae-Yong
    Yhim, Ho-Young
    [J]. BLOOD, 2011, 118 (21) : 882 - 883
  • [49] INTENSIVE TREATMENT OF MULTIPLE-MYELOMA AND CRITERIA FOR COMPLETE REMISSION
    GORE, ME
    VINER, C
    MELDRUM, M
    BELL, J
    MILAN, S
    ZUIABLE, A
    SLEVIN, M
    SELBY, PJ
    CLARK, PI
    MILLAR, B
    MAITLAND, JA
    JUDSON, IR
    TILLYER, C
    MALPAS, JS
    MCELWAIN, TJ
    [J]. LANCET, 1989, 2 (8668): : 879 - 882
  • [50] Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
    Hagen, Patrick
    Norton, Joseph
    Tsai, Stephanie
    Campo, Loredana
    Lee, Mary
    Gomez, Kayeromi
    Stiff, Patrick
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1422 - 1428
12345